By Dave Muoio 04:34 pm September 18, 2020
Contact tracing apps, symptom checkers and other data-driven tools provide tangible benefits, but experts say that more can be done to educate individuals on what information they collect and how it's handled.
By Laura Lovett 03:28 pm September 18, 2020
Some femtech companies struggle to get their ads approved on social media platforms due to prohibited-content rules and confusion of the rules. 
By Sara Mageit 04:49 am September 18, 2020
The startup will use the funding to help expand its platform of patient communication and digital care solutions.
By Tammy Lovell 01:04 am September 18, 2020
Funding will enable the company to expand its app for chronic joint pain to the US and further across Europe.
By Dave Muoio 03:35 pm September 17, 2020
Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.
By Laura Lovett 03:16 pm September 17, 2020
Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold. 
By Mallory Hackett 11:28 am September 17, 2020
Initially, Amwell planned to sell 35 million shares between $14 and $16 with up to 5.2 million additional shares for underwriters. 
By Dave Muoio 10:07 am September 17, 2020
A new analysis of published RCTs did see significant benefits among short-term and single-focus app interventions, but noted that "relatively few high-quality studies have been conducted" in this area.
By Dean Koh 03:17 am September 17, 2020
The LumiHealth app is available in the App Store for pre-order now, and the two-year program will be offered from late October 2020.
By Dave Muoio 03:35 pm September 16, 2020
Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.